A join point regression analysis of trends in mortality due to osteoporosis in Spain

被引:35
作者
Dragomirescu, Ioana [1 ]
Llorca, Javier [1 ,2 ,3 ]
Gomez-Acebo, Ines [1 ,2 ,3 ]
Dierssen-Sotos, Trinidad [1 ,2 ,3 ]
机构
[1] Univ Cantabria, Sch Med, Santander, Spain
[2] IDIVAL, Santander, Spain
[3] CIBERESP, Santander, Spain
关键词
HIP FRACTURE RATES; SECULAR TRENDS; EXCESS MORTALITY; BIRTH-COHORT; BONE-DENSITY; WOMEN; AGE; PREVALENCE; RISK; CARE;
D O I
10.1038/s41598-019-40806-0
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Osteoporosis is a major health problem in terms of fracture probability and disability. The aim of this ecological study is to identify the temporal trends in osteoporosis mortality in Spain from 1999 to 2015. Data on the Spanish population and number of deaths due to osteoporosis were obtained from the Spanish National Institute for Statistics. Age-adjusted mortality rates were estimated. Join point regression was used to identify the years when changes in mortality s and annual percentage change in mortality rates took place. Women presented a greater mortality rate decrease (p < 0.001), though this mortality difference by sex was reduced by half at the end of the period. The higher the age, the faster the mortality rate declined in women, while no clear pattern could be identified in men. In women, significant changes in trends were identified in three age groups (50-54, 60-64 and 80-84 years old). A sustained decrease in osteoporosis-associated mortality was found in women aged 75-79 and >= 85 years and men aged 60-64. In conclusion, mortality caused by osteoporosis in Spain is decreasing faster in the older age ranges especially in women.
引用
收藏
页数:8
相关论文
共 60 条
[1]  
Abrahamsen Bo, 2012, Front Endocrinol (Lausanne), V3, P2, DOI 10.3389/fendo.2012.00002
[2]   European Association of Urology. Position statement on screening for prostate cancer [J].
Abrahamsson, P. A. ;
Artibani, W. ;
Chapple, C. R. ;
Wirth, M. .
ACTAS UROLOGICAS ESPANOLAS, 2010, 34 (03) :221-222
[3]   Screening and Treatment of Osteoporosis After Hip Fracture: Comparison of Sex and Race [J].
Antonelli, Maria ;
Einstadter, Douglas ;
Magrey, Marina .
JOURNAL OF CLINICAL DENSITOMETRY, 2014, 17 (04) :479-483
[4]   Changing trends in the epidemiology of hip fracture in Spain [J].
Azagra, R. ;
Lopez-Exposito, F. ;
Martin-Sanchez, J. C. ;
Aguye, A. ;
Moreno, N. ;
Cooper, C. ;
Diez-Perez, A. ;
Dennison, E. M. .
OSTEOPOROSIS INTERNATIONAL, 2014, 25 (04) :1267-1274
[5]   Utilization of hormone replacement therapy in Spain: Trends in the period 2000-2014 [J].
Balade Martinez, Laura ;
Montero Corominas, Dolores ;
Macias Saint-Gerons, Diego .
MEDICINA CLINICA, 2016, 147 (07) :287-292
[6]   Secular Trends in Hip Fractures Worldwide: Opposing Trends East Versus West [J].
Ballane, Ghada ;
Cauley, Jane A. ;
Luckey, Marjorie M. ;
El-Hajj Fuleihan, Ghada .
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (08) :1745-1755
[7]   Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis [J].
Bolland, Mark J. ;
Grey, Andrew B. ;
Gamble, Greg D. ;
Reid, Ian R. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (03) :1174-1181
[8]   Menopausal Hormone Therapy, Age, and Chronic Diseases: Perspectives on Statistical Trends [J].
Bolton, Judy L. .
CHEMICAL RESEARCH IN TOXICOLOGY, 2016, 29 (10) :1583-1590
[9]   A critical review of brand and generic alendronate for the treatment of osteoporosis [J].
Brown, Jacques P. ;
Davison, Kenneth S. ;
Olszynski, Wojciech P. ;
Beattie, Karen A. ;
Adachi, Jonathan D. .
SPRINGERPLUS, 2013, 2
[10]  
Cheng N, 2008, CAN FAM PHYSICIAN, V54, P1140